Price (delayed)
$15.22
Market cap
$1.35B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.79
Enterprise value
$1.69B
Travere Therapeutics is a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this
There are no recent dividends present for TVTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.